As many as 80 % more patients were treated with experimental vs. control in the DAD-2 than with the BRD-2 ( experimental vs. control ratio : 1.8 vs. 1.0 ) , and as many as 64 % more in the DAD-2 than with the DAD-1 ( 1.8 vs. 1.1 ) .